Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
yeah thanks for this post... great point
didn't know about Yuen
Kinda crazy he served as Director of Valence Technology. I had shares in that company before it went bankrupt. Thing was I didn't know they were undergoing Chapter 11. Good thing he got out years before that happened though.
With his experience he should be looking at making bank with PMCB.
I'm really strapped for cash atm and I want to scrap some of my shares :/ but don't want to miss anything.
I got out years ago in PLUG power when I bought it at 50 cents and when I sold it, it then jumped to 1$, 2$, then 4$, then all the way to 12$.
Now it's down to 1$ again, but that was a huge ride and I could have made some very decent money.
Don't want to make the same mistake twice :/
Idk why you keep saying that old data is useless, as if bringing that up actually means anything. The point of a phase 2b is to get new data.
You can think what you like, but I still believe in PMCB & CIAB. I don't think I've ever heard one positive thing from you about Pharmacyte. You post here everyday, but that's none of my business. I don't know what your motives are and I don't care.
IND is what we wait for, even if it takes a year, PMCB will get there. I am just able to evaluate both the positives and the negatives. The positives outweigh the negatives IMO and the reward is worth the risk.
Yeah looks like a great candidate to invest in.
However, once PMCB gets CIAB out on the market, their treatment for PC will likely be obsolete. CIAB treatment for PC has no side effects, plus many more options down the road with other diseases.
1 billion shares outstanding with no revenue isn't all that great. So PMCB can be looked at as a bad investment, or a good one.
Glass half full or half empty?
I know PMCB still has plans to get on the NASDAQ. What's always been great about this goal is that in order to be listed on that exchange you need a minimum price of 1.00$ per share to stay listed, and 4$ per share to move from OTC to NASDAQ.
1 billion market cap to 4 billion
It will take about 5 years I believe. Minimum couple years after CIAB for PC is in the market.
I have faith that it will get there eventually, but the question is when... so we wait.
I am pro as well, but let's not get fanatical. Extremes of any kind aren't good imo.
Well I'm not against it. I have money invested so a kaboom would be great.
It's just recently I was looking at posts months back, and from last year, where nearly every message was "Kaboom time"
It was terribly annoying to read, especially with my knowledge of our latest news. They are just as annoying as the posts that keep saying PMCB is a failure or a scam, when it hasn't even completed a trial.
I'm really in the middle and I think everyone should be as well. I'm optimistic, but skeptical. Once we get IND then I'll start cheering Kaboom kaboom, but until then let's be a bit more moderate.
Good point about the financial crisis in 2008. A lot of companies went bankrupt at that time. I had not thought about this before.
Word of advice to longs.
Can we stop with the kaboom this and kaboom that?
Buyouts aren't going to happen tomorrow and probably not even this year. Nobody is going to buyout PMCB without at least a Phase 2b trial completion. Why would a company take such a huge risk and buyout something that it then needs to prove? The possibility remains that PMCB's CIAB might fail.
IND submission is going to take at least until summer time, by the looks of it, but more likely to happen in September or August. Then they have to get their ducks in a row and commence the trial, which will take about 3-6 months.
The earliest a buyout will happen will be next year, and that's IF trials are good.
I fully believe in PMCB & the tech. It's easy to understand.
However, saying that it's "kaboom time" nearly every day for months on end seems very naive.
I don't believe this is a scam, but I do believe this company is facing problems and obstacles to getting an IND submitted and CIAB in a trial.
Nobody knows when it's all going to happen, but right now we have no assurance it's going to be any time soon.
Sometimes you just have to slog through the mud. The end goal is to get into trials and that's what they're doing. It's slow & messy but they are moving one step at a time.
Not worth dumping imo. Price is too low. I see the price is only going to continue to increase from here on out.
It's a phase 2b settled. We're waiting for the completion of testing. Then it's IND. PMCB doesn't have a date set in stone, no deadline, because they don't want to sell anymore false promises.
People are going to buy in anticipation of IND/other positive news.
Best time to buy is now, if it gets filed before summer. At least you can average down, even if it gets filed "later this year".
welcome to the board... take everything said here with a grain of salt
Good news, so now we can put the phase 2b thing to rest
Now it's officially out in the open
get ready for that bounce back
shorts better cover
huh is that so?
Well the good news is that they expect the trial to be very large. Large enough to warrant TD2 to exit.
In my opinion, PMCB keeps hitting obstacles that incur delays quite frequently, and I genuinely believe they are doing everything they can to get to trials.
It still bothers me that Phase 2b wasn't announced publicly through a PR. If it really wasn't/isn't a big deal that we're doing a Phase 2B then why hide it in an 8k? I don't buy the glitch, because Monday's PR had nothing mentioning a Phase 2b change.
I think they were hoping for a fast track approval & pivotal trial, and didn't bet that they couldn't get it, so when they realized they couldn't get it, they needed to redo everything again, and that's why we're getting the "later this year" thing.
It's hard to say, but it would really surprise me if IND was filed by summer time or even earlier.
1 million shares on the bid right now
Well good news for us if short volume is still high. Don't think it's going to tank any lower, so shorts will have to buy shares to cover.
I thought it was a PR
Im all for PMCB since I'm long, but I think the middle ground, instead of saying its a scam or that we'r going to get a buyout next month is obviously closer to there being a delay in trial design & IND submission. I am also bracing myself for a PR stating there is a delay since they need to redesign trials for a phase 2b and not a pivaotal
Hope that makes sense my post was kind of rushed
Im all for PMCB since I'm long, but I think the middle ground, instead of saying its a scam or that we'r going to get a buyout next month is obviously closer to there being a delay in trial design & IND submission. I am also bracing myself for a PR stating there is a delay since they need to redesign trials for a phase 2b and not a pivaotal
Hope that makes sense my post was kind of rushed
Sure has been a while since I last time I checked. I don't watch the volume every day so I wouldn't know, but it definitely feels like it's been a little while. Most volume I've noticed (when I have actually glanced at it) been around 300k.
So high volume + green stable + (seemingly) bad news/red flag = we will be ok
I've seen PMCB take larger hits than this. I remember at the turn of 2015 there was some company trying to investigate PMCB and they did a PR that tanked the price to about 3 cents a share.
Nothing came out of that and I think it was a bogus PR. PMCB recovered and those were the days when there was a lot more uncertainty in our future. At least now we know that trials are very viable, since we have cell banks redone & submitting for IND.
Matter of time, but PMCB is really bad with taking a straight line to the finish.
Well rcstock, lemme just say that I was expecting the stock to drop below 5 cents today. So the very fact that we are in the green tells me that we will be ok for now. 7 cents would be great again, but I'm quite happy that we are not in the red right now.
Doesn't look like a dead cat to me. Seems really stable and only continuing to go up.
Dead cats fall back down as soon as they jump.
If it's this strong today, considering the 8-k mixup, then we have good chances it's only going to continue to increase.
The worst behind us?
I only wish. For all I know there will be further mix ups and delays.
Sigh.
Go PMCB
Looks like a comeback!
If prices go up this week, it will give me a lot of confidence to keep holding. I feel like if we can tank this hit and recover, we'll make it to IND, even if it takes us till the end of the year, just hopefully not any longer.
Still hope it was a legitimate glitch, but man, that is one heck of a faux pas to have your investors discover crucial information like that.
Surprised we are in the green, like at all today.
Hope I'm wrong about all this. Still rooting for you PMCB.
I am not bashing my own investment. I am having an open and unbiased discussion about what I bought and if it still is a sound investment to keep and hold on to. I am not going to be blinded by wearing rose colored glasses all the time and refusing to take them off.
HachsbigM, we can let it ride sure, but do we wanna ride this thing in the ground or get out before we hit ground zero?
It's extremely incompetent to have filed an 8-k with crucial info that should have been put out for the general public way before it was stuffed into a legal financial document.
I am honestly questioning my position right now, because I am getting red flags.
Now this PR only sends another red flag. No mention of trial change. You think this is honest?
Nothing regarding Phase 2B, where's the Glitch in the system?
A planned PR for cell bank completion, but nothing for changing from Pivotal to Phase 2b.
Why?
Was it deliberately hidden? There is no way, that out there is a PR lost somewhere in cyberspace, that was supposed to inform everyone that we are now switching from Pivotal to Phase 2b.
Nothing. I'm a strong long here, but this looks very, very bad imo.
"PharmaCyte is working on an IND to submit to the FDA so that it can begin a clinical trial involving locally advanced, inoperable, non-metastatic pancreatic cancer and expects to submit its IND later this year. "
I told you so. Best bet is end of the year. Not end of Q1, maybe in the summer, but looking like Sept.-Nov.
Will take 2 years realistically :/ for a phase 2b
If we don't get bought out after that then it will take another 2 more years if not 3 for a phase 3.
Total 2-5 years before we see anything. Being realistic here.
Give them the benefit of the doubt, but PMCB's PPS will suffer for months now. Only IND will recover PPS at this point.
From the looks of it, they will release a press release saying they need more time to submit an IND, because now they are redesigning for Phase 2B - and they need to readjust facilities etc..
My opinion is that IND gets filed, best scenario - Summer or September. Most realistic scenario is that IND gets filed end of the year.
I still believe in PMCB, but I think people are too optimistic. It's true that PMCB promises every year, but always under delivers.
It delivers, but underwhelmingly so.
Look I doubt we are going to get TD2 back. Nobody is going to spend years preparing for a pivotal, getting rid of TD2, only to take 5 steps back, and chase TD2 again. That seems like a colossal waste of time.
Right now I don't care who does the trials. JUST DO THE TRIALS.
1234 I'm pretty sure the CEO is pretty motivated.
If I had over a few million shares I would do everything possible to succeed and get that buy out.
The problem is there are things that are completely unseen with delays/problems etc. change of plans etc.
1234 I think its very likely...
It will likely drop down to 2 cents or so until they fix their mistake with the PR/8-k Phase 2b delay.
I think price will only recover and start moving somewhere positive when IND is submitted.
It may be a while.
My estimate is that price won't recover till summer.
Only a guess, but this will take a while to recover.
Well this is good news at least that they admit it.
Possibly good news?
So Ive been reading up on price to book ratio and our price to book ratio increases:
Assumed offering price per share $ 0.071
Net tangible book value per share $ 0.004
Increase in net tangible book value per share attributable to the offering $ 0.017
As-adjusted net tangible book value per share after giving effect to the offering $ 0.021
Dilution in net tangible book value per share to new investors $ 0.050
So from a ration of .057/.004= 14.25
to a ratio of .057/.021= 2.71
In essence, while still generally overpriced based on this ratio its nearly 3 times closer to the actual valuation of PMCB.
Someone correct me if I'm wrong in my understanding here.
Does not look good:
Sales of a substantial number of shares of our common stock in the public markets could depress the market price of our common stock and impair our ability to raise capital through the sale of additional equity securities. We cannot predict the effect that future sales of our common stock would have on the market price of our common stock
So essentially, they are saying that they are selling off all their shares which can tank the price so low that there will no longer be any recovery.
Thoughts from veterans?
More:
We have broad discretion in the use of the net proceeds from this offering and may not use them effectively.
We intend to use the net proceeds from this offering for general corporate purposes, which may include, but are not limited to, working capital, capital expenditures, business development and research and development expenditures and acquisitions of new technologies or businesses. However, our management will have broad discretion in the application of the net proceeds from this offering and could spend the proceeds in ways that do not improve our results of operations or enhance the value of our common stock. The failure by management to apply these funds effectively could result in financial losses that could have a material adverse effect on our business, cause the price of our common stock to decline and delay the development of our product candidates.
I'm still reading and wrapping my head around the offering. My understand is that stock price will drop to 2 cents?
I still don't understand everything 100% but learning.
I am a hard long, but brace yourselves:
Based on advice from our consulting oncologists, our Chief Medical Officer and our Advisory Board regarding our planned trial design, we have determined that the data contained in previous clinical trial reports are not enough to fully support a Phase 3 pivotal trial and therefore we are designing a Phase 2b clinical trial that, if successful, we believe will provide the information necessary for a successful Phase 3 pivotal trial. Therefore, our determination to first conduct a Phase 2b clinical trial before conducting a pivotal Phase 3 trial will likely result in additional costs to us and resultant delays in the regulatory review process and any future commercialization and marketing, if regulatory approval is obtained.
May be a while longer before anything happens. If/when IND is submitted will tell us a lot, but right now it's unknown.
Regarding share price dilution from the offering it's 0.05 a share? Anyone with some decent experience explain that part to me?
Not really. It's just basic stock politics.
You have to look at the big picture. We've got world renown oncologists working with us & many other great things.
Just wait for the IND and trial.
Lol I wouldn't sell tomorrow, or next month, or probably not even next year.
This isn't a quick 2 buck profit.